SARS-CoV-2 (Spike Protein) Omicron/B.1.1.529 Mutation Peptide Pool, STEMCELL Technologies (CAT#: STEM-CT-0827-ZJF)

Stimulating T cells with SARS-CoV-2 (Spike Protein) Omicron/B.1.1.529 Mutation Peptide Pool releases downstream cytokines and upregulates activation markers, enabling antigen-specific T cells to be detected or isolated for analysis. A lyophilized mixture of 80 peptides of the spike glycoprotein of SARS-CoV-2 Omicron variant (B.1.1.529), these peptides selectively cover the mutated regions in the spike protein of the SARS-CoV-2 Omicron variant, compared to wild-type. Through interactions with the angiotensin-converting enzyme 2 (ACE2) receptor, the spike protein enables the virus to attach to the cell membrane, and plays a critical role in viral entry (Hoffmann et al.; Walls et al.). Viral peptide pools are useful for a broad range of applications, including vaccine development, immunological research, and diagnostic assay development.

Subtype: Peptide Pools
Species: Other
Application: Activation, Cell Culture
Area of Interest: Infectious Diseases
Purity: Average 70%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

HIV (HLA Class I Control) Peptide Pool, STEMCELL Technologies
SARS-CoV-2 (Spike Protein) Omicron/B.1.1.529 WT Reference Peptide Pool, STEMCELL Technologies
SARS-CoV-2 (Spike Protein) Delta/B.1.617.2 Mutation Peptide Pool, STEMCELL Technologies
SARS-CoV-2 (Spike Protein) Delta/B.1.617.2 WT Reference Peptide Pool, STEMCELL Technologies